SureTrader
Home > Boards > US Listed > Biotechs > Viking Therapeutics, Inc. (VKTX)

I agree on that. Genuine questions around the

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Titan V Member Profile
 
Followed By 32
Posts 3,447
Boards Moderated 1
Alias Born 01/29/12
160x600 placeholder
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) "Edgar (US Regulatory)" - 1/16/2018 5:19:34 PM
Securities Registration Statement (s-1/a) "Edgar (US Regulatory)" - 1/9/2018 5:30:14 PM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 1/4/2018 4:16:58 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 1/3/2018 4:20:47 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 1/3/2018 4:20:21 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 1/3/2018 4:19:30 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 1/3/2018 4:19:04 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 1/3/2018 4:18:12 PM
Viking Therapeutics to Present at Biotech Showcase 2018 "PR Newswire (US)" - 1/2/2018 7:05:00 AM
Securities Registration Statement (s-1) "Edgar (US Regulatory)" - 12/20/2017 5:22:34 PM
Statement of Ownership (sc 13g) "Edgar (US Regulatory)" - 12/19/2017 2:24:35 PM
Statement of Ownership (sc 13g) "Edgar (US Regulatory)" - 12/18/2017 9:57:21 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 12/11/2017 4:26:56 PM
Viking Therapeutics Announces Closing of Public Offering of Common Stock "PR Newswire (US)" - 12/11/2017 4:15:00 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 12/7/2017 4:40:46 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 12/7/2017 6:04:54 AM
Viking Therapeutics Announces Pricing of $12.8 Million Public Offering of Common Stock "PR Newswire (US)" - 12/6/2017 8:08:00 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 12/5/2017 4:30:49 PM
Viking Therapeutics Announces Proposed Public Offering of Common Stock "PR Newswire (US)" - 12/5/2017 4:18:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/28/2017 7:08:18 AM
Viking Therapeutics Announces Positive Top-Line Results from Phase 2 Study of VK5211 in Patients Recovering from Hip Fracture "PR Newswire (US)" - 11/28/2017 7:02:00 AM
Investor Expectations to Drive Momentum within Vector Group, NovoCure, ORBCOMM, Ecolab, Bank of America, and Viking Therapeut... "GlobeNewswire Inc." - 11/20/2017 8:20:00 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 11/8/2017 5:12:26 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/8/2017 4:13:01 PM
Viking Therapeutics Reports Third Quarter 2017 Financial Results and Provides Corporate Update "PR Newswire (US)" - 11/8/2017 4:05:00 PM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist